Proteostasis Therapeutics, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Proteostasis Therapeutics, Inc..The latest application filed is for "proteasome activity enhancing compounds".

Company Profile

31.43.46

Proteostasis Therapeutics, Inc. - Boston MA US
Proteostasis Therapeutics, Inc. - Cambridge MA US
PROTEOSTASIS THERAPEUTICS, INC. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Proteasome Activity Enhancing Compounds App 20220298181 - Cullen; Matthew ; et al.	2022-09-22
Compounds, Compositions, And Methods For Modulating Cftr App 20220227739 - Munoz; Benito ; et al.	2022-07-21
Methods Of Treating Pulmonary Diseases And Disorders App 20220175735 - Miller; John ; et al.	2022-06-09
Compounds, compositions, and methods for modulating CFTR Grant 11,248,010 - Munoz , et al. February 15, 2	2022-02-15
Proteasome activity enhancing compounds Grant 11,242,361 - Cullen , et al. February 8, 2	2022-02-08
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20210369749 - Parks; Daniel ; et al.	2021-12-02
Compounds, compositions, and methods for modulating CFTR Grant 11,136,313 - Munoz , et al. October 5, 2	2021-10-05
Compounds, compositions, and methods for increasing CFTR activity Grant 11,098,035 - Bastos , et al. August 24, 2	2021-08-24
Compounds, compositions, and methods of increasing CFTR activity Grant 11,083,709 - Munoz , et al. August 10, 2	2021-08-10
Proteasome Activity Enhancing Compounds App 20210188802 - Cullen; Matthew ; et al.	2021-06-24
Proteasome Activity Enhancing Compounds App 20210115057 - Cullen; Matthew ; et al.	2021-04-22
Compounds, Compositions, And Methods For Modulating Cftr App 20210061823 - Munoz; Benito ; et al.	2021-03-04
Compounds, compositions, and methods for increasing CFTR activity Grant 10,899,751 - Parks , et al. January 26, 2	2021-01-26
Compounds, Compositions, And Methods For Modulating Cftr App 20200385365 - Munoz; Benito ; et al.	2020-12-10
Compounds, Compositions, And Methods Of Increasing Cftr Activity App 20200360348 - Munoz; Benito ; et al.	2020-11-19
Methods Of Quantifying Cftr Protein Expression App 20200340984 - Kanmert; Daniel ; et al.	2020-10-29
Proteasome Activity Enhancing Compounds App 20200308198 - Cullen; Matthew ; et al.	2020-10-01
Proteostasis Regulators App 20200299270 - Foley; Megan ; et al.	2020-09-24
Compounds, compositions, and methods for increasing CFTR activity Grant 10,738,040 - Bastos , et al. A	2020-08-11
Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis Grant 10,738,011 - Bastos , et al. A	2020-08-11
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20200190072 - Bastos; Cecilia M. ; et al.	2020-06-18
Compounds, compositions, and methods for modulating CFTR Grant 10,662,207 - Munoz , et al.	2020-05-26
4-sulfonylaminocarbonylquinoline Derivatives For Increasing Cftr Activity App 20200055844 - PARKS; Daniel ; et al.	2020-02-20
Compounds, compositions, and methods of increasing CFTR activity Grant 10,548,878 - Munoz , et al. Fe	2020-02-04
Compounds, compositions, and methods for modulating CFTR Grant 10,550,106 - Munoz , et al. Fe	2020-02-04
Proteostasis regulators Grant 10,532,996 - Foley , et al. Ja	2020-01-14
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20200010461 - Parks; Daniel ; et al.	2020-01-09
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20190308960 - Bastos; Cecilia M. ; et al.	2019-10-10
Compounds, compositions, and methods for increasing CFTR activity Grant 10,392,372 - Bastos , et al. A	2019-08-27
Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis Grant 10,392,378 - Bastos , et al. A	2019-08-27
N-phenyl-2-(3-phenyl-6-oxo-1,6-dihydropyridazin-1-yl)acetamide Derivatives For Treating Cystic Fibrosis App 20190256474 - Parks; Daniel ; et al.	2019-08-22
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20190248765 - Parks; Daniel ; et al.	2019-08-15
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20190248779 - Parks; Daniel ; et al.	2019-08-15
Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis Grant 10,344,023 - Bastos , et al. July 9, 2	2019-07-09
Methods Of Identifying Cftr Modulators App 20190154661 - Miller; John ; et al.	2019-05-23
Compounds, Compositions, And Methods For Modulating Cftr App 20190153000 - Munoz; Benito ; et al.	2019-05-23
Methods Of Treating Pulmonary Diseases And Disorders App 20190022071 - Lee; Po-Shun	2019-01-24
Compounds, compositions, and methods for increasing CFTR activity Grant 10,174,014 - Bastos , et al. J	2019-01-08
Methods Of Treating Pulmonary Diseases And Disorders App 20180369209 - Miller; John ; et al.	2018-12-27
Derivatives Of 5-(hetero)arylpyrazol-3-carboxylic Amide Or 1-(hetero)aryltriazol-4-carboxylic Amide Useful For The Treatment Of Inter Alia Cystic Fibrosis App 20180327363 - Bastos; Cecilia M. ; et al.	2018-11-15
Compounds, Compositions, And Methods For Modulating Cftr App 20180291006 - Munoz; Benito ; et al.	2018-10-11
Proteasome Activity Enhancing Compounds App 20180282352 - Cullen; Matthew ; et al.	2018-10-04
Compounds, Compositions, And Methods Of Increasing Cftr Activity App 20180214419 - Munoz; Benito ; et al.	2018-08-02
Compounds, compositions, and methods for increasing CFTR activity Grant 10,017,503 - Bastos , et al. July 10, 2	2018-07-10
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20180147187 - Bastos; Cecilia M. ; et al.	2018-05-31
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20180127400 - Bastos; Cecilia M. ; et al.	2018-05-10
Derivatives Of 5-phenyl- Or 5-heteroarylathiazol-2-carboxylic Amide Useful For The Treatment Of Inter Alia Cystic Fibrosis App 20170369482 - Bastos; Cecilia M. ; et al.	2017-12-28
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20170369480 - Bastos; Cecilia M. ; et al.	2017-12-28
Proteasome activity enhancing compounds Grant 9,850,262 - Cullen , et al. December 26, 2	2017-12-26
Derivatives Of 3-heteroarylisoxazol-5-carboxylic Amide Useful For The Treatment Of Inter Alia Cystic Fibrosis App 20170362214 - Bastos; Cecilia M. ; et al.	2017-12-21
Compounds, compositions, and methods for increasing CFTR activity Grant 9,790,219 - Bastos , et al. October 17, 2	2017-10-17
Proteostasis Regulators App 20170247355 - Foley; Megan ; et al.	2017-08-31
Compounds, compositions, and methods for increasing CFTR activity Grant 9,745,292 - Bastos , et al. August 29, 2	2017-08-29
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20170233379 - Bastos; Cecilia M. ; et al.	2017-08-17
Proteostasis regulators Grant 9,556,166 - Foley , et al. January 31, 2	2017-01-31
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20170001991 - Bastos; Cecilia M. ; et al.	2017-01-05
Proteasome Activity Enhancing Compounds App 20160333031 - Cullen; Matthew ; et al.	2016-11-17
Proteasome activity modulating compounds Grant 9,399,647 - Chambers , et al. July 26, 2	2016-07-26
Methods Of Modulating Cftr Activity App 20160151335 - Tait; Bradley ; et al.	2016-06-02
Proteasome Activity Enhancing Compounds App 20150166567 - Chambers; Robert J. ; et al.	2015-06-18
Proteasome Activity Modulating Compounds App 20150166565 - Chambers; Robert J. ; et al.	2015-06-18
Compounds For Treating Protein Folding Disorders App 20130072473 - Tait; Bradley ; et al.	2013-03-21
Proteostasis Regulators App 20120316193 - Foley; Megan ; et al.	2012-12-13

Company Registrations

NCAGE Code	6V1R1	PROTEOSTASIS THERAPEUTICS, INC.
CAGE Code	6V1R1	PROTEOSTASIS THERAPEUTICS, INC.
SEC	0001445283	PROTEOSTASIS THERAPEUTICS, INC. of DELAWARE